All PODD Content

Insulet Corporation (PODD) Sec Form 8K

Insulet Corporation (NASDAQ: PODD) Sec Form 8K

March 13, 20261 min read

Insulet Corporation (PODD) Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S.

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 12, 20261 min read

Insulet Corporation (PODD) Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 11, 20261 min read

Insulet Corporation (PODD) Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Corporation (NASDAQ: PODD) FY 2026 Other Release

March 10, 20261 min read

Insulet Corporation (PODD) Sec Form 8K

Insulet Corporation (NASDAQ: PODD) Sec Form 8K

March 6, 20261 min read

Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript

Insulet Corporation (NASDAQ: PODD) Q4 2025 Earnings Call dated Feb. 18, 2026 Corporate Participants: Clare Trachtman — Vice President of...

February 20, 202646 min read

Insulet Corporation (PODD) Sec Form 10K

Insulet Corporation (NASDAQ: PODD) Sec Form 10K

February 19, 20261 min read

Insulet Corporation (PODD) Sec Form 8K

Insulet Corporation (NASDAQ: PODD) Sec Form 8K

February 19, 20261 min read

Earnings Previews

Insulet Corporation Reports 31% Annual Revenue Growth; Authorizes $350 Million Repurchase Increase

The global medical technology leader exceeded 2025 financial targets behind a 44% surge in international sales and the expansion of...

February 18, 20264 min read

Insulet Corporation (PODD) Q4 2025 Earnings Results

Insulet Corporation (NASDAQ: PODD) Q4 2025 Earnings Release

February 18, 20261 min read